Newsroom

Biotechnology

Explore the latest breakthroughs and trends in the Biotechnology sector with our newsroom. From cutting-edge innovations in gene therapy and biopharmaceuticals to advancements in medical research and regulatory updates, we provide essential insights into the scientific developments shaping the future of healthcare and life sciences.


Latest Press Releases

Hancock Jaffe Announces Positive Nasdaq Listing Determination
BiotechnologyCompany Update

Hancock Jaffe Announces Positive Nasdaq Listing Determination

September 21, 2020 8:30 AM

Extension Granted for Continued Listing IRVINE, CA / ACCESSWIRE / September 21, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Company has received formal notification that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Capital Market pursuant to an extension through December...

Read more
Pieris Pharmaceuticals Presents Updated Data from Phase 1 Monotherapy and Atezolizumab Combination Studies of 4-1BB/HER2 Bispecific PRS-343 at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
BiotechnologyCompany Update

Pieris Pharmaceuticals Presents Updated Data from Phase 1 Monotherapy and Atezolizumab Combination Studies of 4-1BB/HER2 Bispecific PRS-343 at the European Society for Medical Oncology (ESMO) Virtual Congress 2020

September 20, 2020 11:00 AM

Clinical benefit in both trials, including one confirmed complete response and three partial responses in the monotherapy trial and four confirmed partial responses in the atezolizumab combination trial Robust durability of response in both trials, including more than 18 months in the combination trial Biomarker data, including substantial CD8+ T cell expansion and soluble 4-1BB increase, suggest 4-1BB-driven activity BOSTON, MA /...

Read more
Dr. Scott Brooks, Head of Food Safety at Tyson Foods, Joins Novalent Biotech’s Scientific Advisory Team
BiotechnologyManagement Changes

Dr. Scott Brooks, Head of Food Safety at Tyson Foods, Joins Novalent Biotech’s Scientific Advisory Team

September 18, 2020 3:16 PM

GREENSBORO, NC / ACCESSWIRE / September 18, 2020 / Novalent Biotech, Inc (‘Novalent'), a US biotechnology engineering firm, has announced the appointment of Dr. Scott Brooks, Head of Food Safety at Tyson Foods, to Novalent's Scientific Advisory Board. Novalent has revolutionized food safety by developing a patented technology which provides a safe and protective antimicrobial layer on surfaces that continuously inhibits the growth of...

Read more
DECN Announces Finalizing of International Genviro! COVID-19 Saliva Swift Kits for Global Market and Establishes Introductory Sales Pricing
BiotechnologyProduct Announcements

DECN Announces Finalizing of International Genviro! COVID-19 Saliva Swift Kits for Global Market and Establishes Introductory Sales Pricing

September 18, 2020 9:15 AM

LOS ANGELES, CA / ACCESSWIRE / September 18, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., today announced it is finalizing its Covid-19 Saliva Swift Kits for international use along with its recommended pricing for the global market....

Read more
Pardeep Nijhawan Acquires Beneficial Ownership of Additional Securities of Edesa Biotech, Inc.
BiotechnologyCompany Update

Pardeep Nijhawan Acquires Beneficial Ownership of Additional Securities of Edesa Biotech, Inc.

September 18, 2020 8:10 AM

MARKHAM, ON / ACCESSWIRE / September 18, 2020 / Dr. Pardeep Nijhawan ("Dr. Nijhawan") announces that his beneficial ownership of common shares ("Common Shares") in the capital of Edesa Biotech, Inc. ("Edesa") has increased by more than 2% of the issued and outstanding Common Shares from the amount reported in the early warning report Dr. Nijhawan filed dated May 11, 2020 (the "Previous Report"). The requirement to file this press release and...

Read more
Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development
BiotechnologyPartnerships

Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development

September 17, 2020 8:30 AM

LIANYUNGANG, CHINA and JUPITER, FL / ACCESSWIRE / September 17, 2020 / Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced collaboration with Jiangsu Hengrui Medicine Co.,...

Read more
Applied UV, Inc. Subsidiary, SteriLumen, Inc. Installs First Ultraviolet Light Disinfecting Devices at Mt. Sinai St. Luke's Hospital as Part of Evaluation Study
BiotechnologyCompany Update

Applied UV, Inc. Subsidiary, SteriLumen, Inc. Installs First Ultraviolet Light Disinfecting Devices at Mt. Sinai St. Luke's Hospital as Part of Evaluation Study

September 17, 2020 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / September 17, 2020 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") utilizing its patented devices to destroy pathogens safely, thoroughly, and automatically, today announced that its subsidiary, SteriLumen, Inc. ("SteriLumen"), has installed its Disinfecting System in the first of 17...

Read more
Tetra Bio-Pharma Adds Two Board Members and Appoints New COO
BiotechnologyManagement Changes

Tetra Bio-Pharma Adds Two Board Members and Appoints New COO

September 17, 2020 8:00 AM

OTTAWA, ON / ACCESSWIRE / September 17, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP.TO) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that Ms. Dale Weil and Dr. Brent Norton have been appointed to the Company's Board of Directors and Dr. Graham Wood, Ph.D. has been appointed as Chief Operating Officer. Steeve Neron, who served as COO will transition to his new role as...

Read more
Cantabio Pharmaceuticals receives grant from Michael J. Fox Foundation to develop a novel DJ-1 protein-based biomarker for Parkinson's Disease
BiotechnologyCompany Update

Cantabio Pharmaceuticals receives grant from Michael J. Fox Foundation to develop a novel DJ-1 protein-based biomarker for Parkinson's Disease

September 16, 2020 1:15 PM

Grant enables the development of new detection technologies for DJ-1 in biofluids to create a new biomarker for the potential early diagnosis and tracking of the progression of Parkinson's disease PALO ALTO, CA / ACCESSWIRE / September 16, 2020 / Cantabio Pharmaceuticals, Inc. ("Cantabio" or the "Company"), a preclinical stage pharmaceutical company developing disease modifying therapeutics for Alzheimer's (AD), Parkinson's (PD) and Type II...

Read more
Havn Life Sciences Announces Listing Approval on the Frankfurt Stock Exchange
BiotechnologyExchange Listing Upgrade

Havn Life Sciences Announces Listing Approval on the Frankfurt Stock Exchange

September 16, 2020 8:00 AM

Havn Life is now cross-listed and trades on both the CSE & FSE VANCOUVER, BC / ACCESSWIRE / September 16, 2020 / Havn Life Sciences Inc. (CSE:HAVN)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company focused on unlocking human potential using evidence-informed research, and developing standardized psychoactive compounds derived from plants and fungi, is pleased to announce that it has been accepted to list its common shares on...

Read more
Experion Launches Flagship Brand Citizen Stash in Ontario
BiotechnologyCompany Update

Experion Launches Flagship Brand Citizen Stash in Ontario

September 14, 2020 8:45 AM

VANCOUVER, BC / ACCESSWIRE / September 14, 2020 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce that it has completed its first shipment to fulfill an initial purchase order from the Ontario Cannabis Store ("OCS"). This first purchase order consists of Citizen Stash's top strains including MAC1, Sunset Sherbert, Sage N'Sour and Stonewall for 3.5g premium flower....

Read more
Dyadic to Present at Upcoming Investor and Industry Events
BiotechnologyConferences

Dyadic to Present at Upcoming Investor and Industry Events

September 14, 2020 8:30 AM

JUPITER, FL / ACCESSWIRE / September 14, 2020 / Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ:DYAI) a global biotechnology company focused on further improving, applying and deploying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that the Company's management will be attending...

Read more
Yulong Selects Nashville Area to Develop Cellular Biological Drugs
BiotechnologyCompany Update

Yulong Selects Nashville Area to Develop Cellular Biological Drugs

September 14, 2020 8:00 AM

CHEYENNE, WY / ACCESSWIRE / September 14, 2020 / Yulong Eco-Materials Limited (OTC PINK:YECO) today announced that it will focus its energies into building an incubator laboratory in Nashville,TN for the development of cell and extracellular vesicle (EV) based therapeutics. Dr. Jason Sanders recently relocated to Nashville and the Company is now negotiating lab space near the Vanderbilt University area. EV Biologics will develop a new...

Read more
Molecular Partners Completes GMP Manufacturing of Anti-COVID-19 DARPin(R) Candidate MP0420 for Clinical Use
BiotechnologyCompany Update

Molecular Partners Completes GMP Manufacturing of Anti-COVID-19 DARPin(R) Candidate MP0420 for Clinical Use

September 14, 2020 1:00 AM

High yields in bacterial fermentation systems support ability of DARPin® manufacturing to rapidly scale for global supply First and only, tri-specific antiviral demonstrating potential best-in-class potency in vivo First-in-human clinical trial initiation planned for November 2020 ZURICH-SCHLIEREN / ACCESSWIRE / September 14, 2020 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of...

Read more
Experion Announces Chief Financial Officer Change
BiotechnologyManagement Changes

Experion Announces Chief Financial Officer Change

September 11, 2020 8:00 PM

VANCOUVER, BC / ACCESSWIRE / September 11, 2020 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) announced today that its Chief Financial Officer Kamini Hitkari has advised the Company of her decision to resign from the Company to pursue another opportunity. Mr. Sean McNeil, Chairman of the Board of Experion, will act in the capacity of Interim CFO effective immediately. The Company has also...

Read more
Apollo Endosurgery to Present at HC Wainwright Conference
BiotechnologyConferences

Apollo Endosurgery to Present at HC Wainwright Conference

September 11, 2020 3:00 PM

AUSTIN, TX / ACCESSWIRE / September 11, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it will present at the HC Wainwright & Co. Global Investment Conference on Tuesday, September 15 at 3:00 PM Eastern Time. Todd Newton, CEO, and Stefanie Cavanaugh, CFO, will be presenting and available for one-on-one investor...

Read more
Rising Biosciences, Inc. Resumes Trading; Announces New 10,000 SF Headquarters and Bottling Plant
BiotechnologyCompany Update

Rising Biosciences, Inc. Resumes Trading; Announces New 10,000 SF Headquarters and Bottling Plant

September 11, 2020 9:00 AM

SANDUSKY, OH / ACCESSWIRE / September 11, 2020 / Rising Biosciences, Inc. (OTC PINK:RBII) CEO Arthur Hall noted the resumption of trading of RBII stock and announced the Environmental Protection Agency (EPA) has issued Establishment Number 96322-OH-3 for the company's new 10,000 square foot bottling plant and corporate headquarters in Sandusky, OH. "We will begin bottling in our new plant by October 1st, starting with our new product, Oxy...

Read more
Tetra Bio-Pharma Appoints Chief Financial Officer
BiotechnologyManagement Changes

Tetra Bio-Pharma Appoints Chief Financial Officer

September 11, 2020 9:00 AM

OTTAWA, ON / ACCESSWIRE / September 11, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce the appointment of Jean-Francois Boily, CPA, CA, as Chief Financial Officer and member of the Company's executive team. He will join the Company on September 14th bringing vast experience in publicly traded companies (TSX and NASDAQ listed)...

Read more
Molecular Partners to Present at HC Wainwright and Morgan Stanley Healthcare Conferences
BiotechnologyConferences

Molecular Partners to Present at HC Wainwright and Morgan Stanley Healthcare Conferences

September 11, 2020 1:00 AM

ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / September 11, 2020 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built proteins known as DARPin® therapeutics, today announced that Patrick Amstutz, chief executive officer, will be presenting at the HC Wainwright 22nd Annual Global Investments Conference taking place September 14-16, 2020, as well as participating in a fireside chat at...

Read more
NovAccess Global Acquires StemVax Therapeutics from Innovest Global
BiotechnologyCompany Update

NovAccess Global Acquires StemVax Therapeutics from Innovest Global

September 9, 2020 4:01 PM

Acquisition Launches NovAccess Shift, Focusing on Diagnostics and Therapeutics in Cancer CLEVELAND, OH / ACCESSWIRE / September 9, 2020 / NovAccess Global, Inc. (OTCPINK:XSNX), today announced that it has acquired 100% ownership of Pasadena-based StemVax Therapeutics from Innovest Global (OTCPINK:IVST). StemVax is a translational biotechnology company developing novel immunotherapies for brain tumor patients, featuring recently approved...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?